NDC 10135-718

Alendronate

Alendronate Sodium Tablet

Alendronate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is Alendronate Sodium.

Product ID10135-718_b63421af-ec04-1de7-e053-2a95a90abec6
NDC10135-718
Product TypeHuman Prescription Drug
Proprietary NameAlendronate
Generic NameAlendronate Sodium Tablet
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-12-01
Marketing CategoryANDA / ANDA
Application NumberANDA090258
Labeler NameMarlex Pharmaceuticals, Inc.
Substance NameALENDRONATE SODIUM
Active Ingredient Strength35 mg/1
Pharm ClassesBisphosphonate [EPC],Diphosphonates [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 10135-718-12

3 BLISTER PACK in 1 CARTON (10135-718-12) > 4 TABLET in 1 BLISTER PACK
Marketing Start Date2020-12-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Alendronate" or generic name "Alendronate Sodium Tablet"

NDCBrand NameGeneric Name
10135-696AlendronateAlendronate Sodium
10135-697AlendronateAlendronate Sodium
10135-718AlendronateAlendronate sodium tablet
10135-719AlendronateAlendronate sodium tablet
50090-2587AlendronateALENDRONATE SODIUM
50090-3593AlendronateALENDRONATE SODIUM
60723-205AlendronateALENDRONATE SODIUM
60723-207AlendronateALENDRONATE SODIUM
63629-7329AlendronateALENDRONATE SODIUM
68071-4017AlendronateALENDRONATE SODIUM
68071-4072AlendronateALENDRONATE SODIUM
69543-130AlendronateALENDRONATE SODIUM
69543-131AlendronateALENDRONATE SODIUM

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.